Symbols

Symbols

AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial

ATXS(Delisted)

Astria Therapeutics·NASDAQ

--

--(--)

Stock Overview

0.00 / 10Overall Score

—Investment Rating

RiskExcellent

Drawing on fundamental quality of 0.00/10, technical read of 0.00/10, and market sentiment of 0.00/10, ATXS's overall diagnostic stands at 0.00/10 — a — rating.
The five-dimensional fundamental profile of ATXS — Value 0.00, Future 0.00, Past 0.00, Health 0.00, Dividend 0.00 — aggregates to 0.00/10, earning a — rating.
Weighing recent momentum, trend, and candlestick pattern signals, ATXS's technical footprint settles at 0.00/10 — rated —.
The combined read of institutional fund flow activity and sell-side analyst consensus places ATXS's market sentiment at 0.00/10 — a — rating.

Shareholder Returns

ATXSIndustryMarket

7 Day------

30 Day------

90 Day------

1 Year------

3 Year------

5 Year------

Include Dividend Returns

Astria Therapeutics Corporation Fundamentals Summary

--P/E Ratio

--P/S Ratio

--P/B Ratio

Market cap--

Earnings--

Revenue--

Is ATXS a Buy, Sell, or Hold?

Based on a composite score of 5.23/10, we rate ATXS as a Netural. Our analysis breaks down into 6.71/10 for Fundamentals, 3.39/10 for Technicals, and 5.42/10 for Sentiment, indicating the stock is likely to consolidate sideways.

Is ATXS fundamentally strong?

What is the current technical signals for ATXS?

What is the analyst consensus for ATXS?